knowledge -WSS

knowledge

author：entertainment 2025-09-29 05:48:48 Page View：195

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

AdobeTheFoodandDrugAdministrationhasclearedOtsukaPharmaceutical’sdigitaltreatmentformajordepressived

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Bird flu in dairy cattle: New measures to control spread to humans

FarmworkersmilkdairycowsinamilkingparlorinSchuylerville,N.Y.HansPennink/APWASHINGTON—Thefederalgover

knowledge

explore

Wikipedia

Bird flu in dairy cattle: New measures to control spread to humans